First experience of a hemophilia monitoring platform: florio HAEMO.
hemophilia
patient preference
pharmacokinetics
telemedicine
Journal
Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
12
11
2021
revised:
11
01
2022
accepted:
05
02
2022
entrez:
21
3
2022
pubmed:
22
3
2022
medline:
22
3
2022
Statut:
epublish
Résumé
florio HAEMO is a new hemophilia treatment monitoring application consisting of a patient smartphone application (app) and a web-based dashboard for healthcare professionals, providing several novel features, including activity tracking, wearable connectivity, kids and caregiver mode, and real-time pharmacokinetic factor level estimation. To assess intuitiveness, ease-of-use, and patient preference of florio HAEMO in Central Europe using a cross-sectional survey. This survey was conducted in six Central European countries between 9 December 2020 and 24 May 2021. The online questionnaire included 17 questions about overall satisfaction, ease-of-use, intuitiveness, and patient preference. Adults or children with hemophilia on regular prophylaxis and using the florio HAEMO app for a minimum of 1 week were invited to complete the online questionnaire by their treating physician. Sixty-six participants took part in the survey. The median duration for all respondents using the florio HAEMO app was 3 to 4 weeks. Overall, 89.4% of users reported being very satisfied or rather satisfied after using florio HAEMO. Of the 23 respondents who had switched from another hemophilia app, 87.0% indicated that they strongly preferred or preferred using florio HAEMO. Most florio HAEMO users reported that the app was very easy or rather easy to use (97.0%) and intuitive (94.0%). florio HAEMO had a positive impact on daily living, with 78.8% of users reporting that the app was very important or rather important to them. This survey suggests that florio HAEMO is an easy-to-use and intuitive app to assist self-management of home prophylaxis.
Sections du résumé
Background
UNASSIGNED
florio HAEMO is a new hemophilia treatment monitoring application consisting of a patient smartphone application (app) and a web-based dashboard for healthcare professionals, providing several novel features, including activity tracking, wearable connectivity, kids and caregiver mode, and real-time pharmacokinetic factor level estimation.
Objectives
UNASSIGNED
To assess intuitiveness, ease-of-use, and patient preference of florio HAEMO in Central Europe using a cross-sectional survey.
Methods
UNASSIGNED
This survey was conducted in six Central European countries between 9 December 2020 and 24 May 2021. The online questionnaire included 17 questions about overall satisfaction, ease-of-use, intuitiveness, and patient preference. Adults or children with hemophilia on regular prophylaxis and using the florio HAEMO app for a minimum of 1 week were invited to complete the online questionnaire by their treating physician.
Results
UNASSIGNED
Sixty-six participants took part in the survey. The median duration for all respondents using the florio HAEMO app was 3 to 4 weeks. Overall, 89.4% of users reported being very satisfied or rather satisfied after using florio HAEMO. Of the 23 respondents who had switched from another hemophilia app, 87.0% indicated that they strongly preferred or preferred using florio HAEMO. Most florio HAEMO users reported that the app was very easy or rather easy to use (97.0%) and intuitive (94.0%). florio HAEMO had a positive impact on daily living, with 78.8% of users reporting that the app was very important or rather important to them.
Conclusions
UNASSIGNED
This survey suggests that florio HAEMO is an easy-to-use and intuitive app to assist self-management of home prophylaxis.
Identifiants
pubmed: 35308098
doi: 10.1002/rth2.12685
pii: S2475-0379(22)01173-6
pmc: PMC8918679
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12685Informations de copyright
© 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).
Références
Haemophilia. 2006 Mar;12(2):163-8
pubmed: 16476091
Haemophilia. 2020 Nov;26(6):999-1008
pubmed: 33084135
J Thromb Haemost. 2017 Dec;15(12):2461-2465
pubmed: 29119666
Haemophilia. 2021 May;27(3):417-424
pubmed: 33751755
J Health Econ. 2008 Sep;27(5):1275-84
pubmed: 18667254
Haemophilia. 2004 Nov;10(6):698-704
pubmed: 15569164
Hamostaseologie. 2019 Nov;39(4):339-346
pubmed: 30620988
Res Pract Thromb Haemost. 2018 May 20;2(3):535-548
pubmed: 30046759
Haemophilia. 2009 Mar;15(2):464-72
pubmed: 19226411
Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):595-604
pubmed: 29222309
CPT Pharmacometrics Syst Pharmacol. 2019 Dec;8(12):894-903
pubmed: 31668021
Haemophilia. 2017 Sep;23(5):728-735
pubmed: 28806858
Ther Adv Hematol. 2020 Oct 20;11:2040620720966888
pubmed: 33194165
BMJ Open. 2015 Feb 06;5(2):e006448
pubmed: 25659890